In the United States, the cost paid for statins (drugs to lower cholesterol) in people under the age of 65 who have private insurance continues to exceed comparable costs paid by the government in the United Kingdom (U.K.) ...
Nov 1, 2012
1
0
A new drug candidate may be the first capable of halting the devastating mental decline of Alzheimer's disease, based on the findings of a study published today in PLoS One.
Dec 14, 2011
0
0
A genetic discovery will make treatment for Crohn's disease and ulcerative colitis safer, by identifying patients who are at risk of potentially deadly drug side effects.
Feb 26, 2019
0
1572
(Medical Xpress) -- In a new report released by the IMS Institute for Healthcare Informatics, the results show that over 78% of the almost four billion prescriptions written in the U.S. in 2010 were for generic drugs. The ...
For people at high risk of overdose enrolled in a safer opioid supply (SOS) program, there was a rapid decrease in emergency department visits and hospitalizations soon after initiation, according to new research published ...
Sep 19, 2022
0
12
Seeing a physician or other health specialist for low back and neck pain? You're not alone, according to a new scientific study.
Mar 3, 2020
0
379
A second Alzheimer's drug proven to slow cognitive decline was a step closer to US approval on Monday after clinical trial results published in a top journal confirmed its efficacy.
Jul 22, 2023
0
9
A prostate cancer drug won't be offered on the NHS any earlier in the treatment plans of patients living with the disease in England, after it failed to pass a cost-effectiveness review.
Apr 8, 2019
0
2
Novo Nordisk A/S replenished supplies of Ozempic, a treatment for diabetes, after social media-driven enthusiasm over the drug's use for weight loss led to six months of shortages.
Mar 20, 2023
0
2
Prescription drug copayments often exceed the retail cost of a drug, a recent USC study reveals. This means that technically an overpayment occurs, and someone—not the patient—keeps the excess payment.
Aug 31, 2018
0
8
